Rapid Micro Biosystems Inc.

RPID | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.17

+$0.04 (+3.54%)

Sep 22, 2026, 1:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.54%

(1D)

Rating

Updated: Aug 14, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $52.8M

1D Range

1.14 1.18

52W Range

1.09 4.94

Valuation (TTM)

PE -1.02

PB 2.89

EV/EBITDA -1.19

Valuation (NTM)

Forward PE N/A

Forward PEG 0.05

Price Target $7

Cash Flow

FCF Yield -78.9%

SBC Adj. FCF Yield -87.3%

SBC Impact -10.7%

Margins

Gross Margin 10.0%

Operating Margin -141.4%

FCF Margin -114.8%

Growth (CAGR)

Revenue 3Y | 5Y 22.5% | 10.2%

Dil EPS 3Y | 5Y 2.7% | 12.7%

FCF 3Y | 5Y 7.6% | 15.6%

Returns

ROA -87.6%

ROE -177.0%

ROIC -119.5%

Financial Health

Net Debt

$3.71M

Current Ratio 2.55

Interest Coverage -19.82

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devi...

Sector Healthcare

Industry Medical - Devices

Employees 171

IPO Date Jul 14, 2021

Website www.rapidmicrobio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 6, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+498.29%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞